{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:20:37Z","timestamp":1778786437765,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004083","name":"Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["RS-2023\\u201300242790"],"award-info":[{"award-number":["RS-2023\\u201300242790"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["RS-2024\\u201300408736"],"award-info":[{"award-number":["RS-2024\\u201300408736"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010955","name":"GemVax and KAEL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","award":["RS-2024\\u201300335752"],"award-info":[{"award-number":["RS-2024\\u201300335752"]}],"id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117514","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:16:57Z","timestamp":1762096617000},"page":"117514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Therapeutic effects of telomerase-derived peptide GV1001 in experimental autoimmune encephalomyelitis: Inhibiting neuroinflammation and promoting remyelination"],"prefix":"10.1016","volume":"243","author":[{"given":"Jong-Heon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup","family":"Bhusal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Soo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Ha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long Tai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangjae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-4203","authenticated-orcid":false,"given":"Kyoungho","family":"Suk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117514_b0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1381612822666161214153108","article-title":"Multiple Sclerosis and Neuroinflammation: the Overview of current and prospective Therapies","volume":"23","author":"Bjelobaba","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2025.117514_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"Filippi","year":"2018","journal-title":"Multiple Sclerosis. Nat Rev Dis Primers"},{"key":"10.1016\/j.bcp.2025.117514_b0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2025.117514_b0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrd2358","article-title":"Novel therapeutic strategies for multiple sclerosis\u2013a multifaceted adversary","volume":"7","author":"Lopez-Diego","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117514_b0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40263-018-0488-6","article-title":"Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved since 2010","volume":"32","author":"Faissner","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2025.117514_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42466-025-00379-y","article-title":"Should we stay or should we go? recent insights on drug discontinuation in multiple sclerosis","volume":"7","author":"Mrochen","year":"2025","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.bcp.2025.117514_b0035","article-title":"Evolution of Disease Modifying Therapy Benefits and risks: an Argument for De-escalation as a Treatment Paradigm for patients with Multiple Sclerosis","volume":"12","author":"Vollmer","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bcp.2025.117514_b0040","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4103\/1673-5374.194804","article-title":"Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response","volume":"11","author":"Koudriavtseva","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bcp.2025.117514_b0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fimmu.2020.00374","article-title":"Microglia in Multiple Sclerosis: Friend or Foe?","volume":"11","author":"Guerrero","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117514_b0050","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/glia.23980","article-title":"Activated microglia drive demyelination via CSF1R signaling","volume":"69","author":"Marzan","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2025.117514_b0055","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41467-024-46068-3","article-title":"Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation","volume":"15","author":"van den Bosch","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117514_b0060","article-title":"Microglia in the context of multiple sclerosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bcp.2025.117514_b0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12974-024-03019-5","article-title":"Microglia-derived exosomes modulate myelin regeneration via miR-615-5p\/MYRF axis","volume":"21","author":"Ji","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117514_b0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3892\/mmr.2017.6673","article-title":"Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2025.117514_b0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/imm.12177","article-title":"Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis","volume":"141","author":"Giunti","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2025.117514_b0080","article-title":"Microglial Phenotypes and Functions in Multiple Sclerosis","volume":"8","author":"O'Loughlin","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bcp.2025.117514_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588021","article-title":"Microglia Diversity in Health and Multiple Sclerosis","volume":"11","author":"Zia","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117514_b0090","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/sj.bjc.6603437","article-title":"Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I\/II study","volume":"95","author":"Bernhardt","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117514_b0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5853\/jos.2021.00626","article-title":"Neuroprotective Effects of GV1001 in Animal Stroke Model and Neural Cells Subject to Oxygen-Glucose Deprivation\/Reperfusion Injury","volume":"23","author":"Kwon","year":"2021","journal-title":"J Stroke"},{"key":"10.1016\/j.bcp.2025.117514_b0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbi.2023.10.021","article-title":"GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer's disease mouse model","volume":"115","author":"Park","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117514_b0105","article-title":"Protocol for delivering proteins, peptides, and shRNAs via the intrathecal route in the experimental allergic encephalomyelitis mouse model","volume":"5","author":"Bhusal","year":"2024","journal-title":"STAR Protoc."},{"key":"10.1016\/j.bcp.2025.117514_b0110","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1074\/jbc.M113.542282","article-title":"Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues","volume":"289","author":"Nam","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117514_b0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bcp.2025.117514_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113813","article-title":"The microglial innate immune protein PGLYRP1 mediates neuroinflammation and consequent behavioral changes","volume":"43","author":"Bhusal","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.117514_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106808","article-title":"The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice","volume":"87","author":"Azimzadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117514_b0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/glia.20935","article-title":"Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"58","author":"Berard","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2025.117514_b0135","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/glia.23942","article-title":"Satellite glia as a critical component of diabetic neuropathy: role of lipocalin-2 and pyruvate dehydrogenase kinase-2 axis in the dorsal root ganglion","volume":"69","author":"Bhusal","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2025.117514_b0140","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.12688\/f1000research.21142.1","article-title":"Falco: high-speed FastQC emulation for quality control of sequencing data","volume":"8","author":"de Sena Brandine","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.bcp.2025.117514_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bcp.2025.117514_b0150","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","article-title":"Analysing high-throughput sequencing data in Python with HTSeq 2.0","volume":"38","author":"Putri","year":"2022","journal-title":"Bioinformatics"},{"issue":"253\u2013271","key":"10.1016\/j.bcp.2025.117514_b0155","first-page":"e256","article-title":"Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain reveals complex Cell-State changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2025.117514_b0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/glia.10274","article-title":"High-yield isolation of murine microglia by mild trypsinization","volume":"44","author":"Saura","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2025.117514_b0165","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201605","article-title":"A multiplexed siRNA screen identifies key kinase signaling networks of brain glia","volume":"6","author":"Kim","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bcp.2025.117514_b0170","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/nprot.2012.099","article-title":"Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex","volume":"7","author":"Beaudoin","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2025.117514_b0175","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1007\/s10571-023-01380-2","article-title":"Pearls and pitfalls of Isolating Rat OPCs for In Vitro Culture with Different Methods","volume":"43","author":"Janowska","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"Unit3","key":"10.1016\/j.bcp.2025.117514_b0180","first-page":"25","article-title":"Isolation of myelin","volume":"3","author":"Larocca","year":"2007","journal-title":"Curr Protoc Cell Biol Chapter"},{"key":"10.1016\/j.bcp.2025.117514_b0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*Power software","volume":"18","author":"Kang","year":"2021","journal-title":"J Educ Eval Health Prof"},{"key":"10.1016\/j.bcp.2025.117514_b0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.07.029","article-title":"An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis","volume":"143","author":"Cho","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2025.117514_b0195","doi-asserted-by":"crossref","first-page":"385127","DOI":"10.1155\/2015\/385127","article-title":"The Anti-Inflammatory Effect of Human Telomerase-Derived Peptide on P. gingivalis Lipopolysaccharide-Induced Inflammatory Cytokine Production and Its Mechanism in Human Dental Pulp Cells","volume":"2015","author":"Ko","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2025.117514_b0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2016.05.022","article-title":"Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals","volume":"55","author":"Park","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bcp.2025.117514_b0205","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41593-024-01609-3","article-title":"Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis","volume":"27","author":"Mader","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2025.117514_b0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117514_b0215","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2147\/JIR.S364190","article-title":"The Influence of Arginine Methylation in Immunity and Inflammation","volume":"15","author":"Srour","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bcp.2025.117514_b0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1139\/bcb-2023-0212","article-title":"Protein arginine methyltransferase 1, a major regulator of biological processes","volume":"102","author":"Sudhakar","year":"2024","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117514_b0225","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1523\/JNEUROSCI.15-11-07344.1995","article-title":"In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice","volume":"15","author":"Ye","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117514_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117514_b0235","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","article-title":"Cellular pathways influenced by protein arginine methylation: Implications for cancer","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117514_b0240","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1128\/MCB.20.13.4859-4869.2000","article-title":"Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable","volume":"20","author":"Pawlak","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117514_b0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1060781","article-title":"Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor","volume":"293","author":"Wang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117514_b0250","doi-asserted-by":"crossref","first-page":"13059","DOI":"10.1074\/jbc.RA118.002027","article-title":"Arginine methylation of SMAD7 by PRMT1 in TGF-beta-induced epithelial-mesenchymal transition and epithelial stem-cell generation","volume":"293","author":"Katsuno","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117514_b0255","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0022034518755688","article-title":"Smad6 Methylation Represses NFkappaB Activation and Periodontal Inflammation","volume":"97","author":"Zhang","year":"2018","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bcp.2025.117514_b0260","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/nar\/gkn166","article-title":"The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation","volume":"36","author":"Kleinschmidt","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117514_b0265","doi-asserted-by":"crossref","first-page":"40531","DOI":"10.1038\/srep40531","article-title":"Protein arginine methyltransferase 1 (PRMT1) represses MHC II transcription in macrophages by methylating CIITA","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117514_b0270","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molcel.2004.06.042","article-title":"Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes","volume":"15","author":"Mowen","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117514_b0275","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1523\/JNEUROSCI.23-20-07710.2003","article-title":"Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination","volume":"23","author":"Mason","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117514_b0280","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1523\/JNEUROSCI.20-15-05703.2000","article-title":"Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination","volume":"20","author":"Mason","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117514_b0285","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201467","article-title":"PRMT1 is required for the generation of MHC-associated microglia and remyelination in the central nervous system","volume":"5","author":"Lee","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bcp.2025.117514_b0290","first-page":"1983","article-title":"GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects","volume":"16","author":"Park","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2025.117514_b0295","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13195-021-00803-w","article-title":"Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial","volume":"13","author":"Koh","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bcp.2025.117514_b0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12779\/dnd.2023.22.3.100","article-title":"Effects of GV1001 on Language Dysfunction in patients with Moderate-to-Severe Alzheimer's Disease: Post Hoc Analysis of Severe Impairment Battery Subscales","volume":"22","author":"Kwon","year":"2023","journal-title":"Dement Neurocogn Disord"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:54:43Z","timestamp":1775796883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":60,"alternative-id":["S0006295225007798"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117514","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of telomerase-derived peptide GV1001 in experimental autoimmune encephalomyelitis: Inhibiting neuroinflammation and promoting remyelination","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117514"}}